Controlled Substances: Drug Diversion, SUD, and Pain Management
Hours: 3.75
Patient care in any practice setting has become increasingly complicated due to several factors, including but not limited to: Substance use disorders (SUDs), diversion of medications, and management of injuries and illnesses with symptoms of moderate to severe pain. Marketing strategies by the pharmaceutical industry, self-medication of partially treated or undiagnosed illness, an increasing number of older patients, and accepted societal norms surrounding prescription pain management further impede optimal patient care. Recognizing, understanding, and addressing patient behaviors, as well as the rationales behind these behaviors, is critical to successfully manage patients and protect practitioners and their practices. This course will review three major areas complicating patient care: Drug diversion, SUD, and pain management considerations in patients with SUD.
The goal of this course is to equip nurses, social workers, counselors, and physicians in both acute and post-acute care with how to prevent, identify, and manage substance abuse among residents and/or patients.
DSM™ and DSM-5™ are registered trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this course.
Patient care in any practice setting has become increasingly complicated due to several factors, including but not limited to: Substance use disorders (SUDs), diversion of medications, and management of injuries and illnesses with symptoms of moderate to severe pain. Marketing strategies by the pharmaceutical industry, self-medication of partially treated or undiagnosed illness, an increasing number of older patients, and accepted societal norms surrounding prescription pain management further impede optimal patient care. Recognizing, understanding, and addressing patient behaviors, as well as the rationales behind these behaviors, is critical to successfully manage patients and protect practitioners and their practices. This course will review three major areas complicating patient care: Drug diversion, SUD, and pain management considerations in patients with SUD. The goal of this course is to equip nurses, social workers, counselors, and physicians in both acute and post-acute care with how to prevent, identify, and manage substance abuse among residents and/or patients. DSM™ and DSM-5™ are registered trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this course.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 3.75 contact hours for participating in this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 3.7000 contact hours for participating in this course.
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling (CEBroker Provider #50-290)
This activity is approved for 3.75 contact hours.
Ohio Social Worker Board
Ohio Counselor, Social Worker and Marriage and Family Therapist Board (CEBroker Provider # 50-290)
This activity is approved for 3.75 contact hours.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.5000 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 3.75 Nursing Contact Hours after successfully completing this course.
Association of Social Work Boards
As a Jointly Accredited Organization, Relias LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Relias LLC maintains responsibility for this course. Social workers completing this course receive 3.75 Clinical continuing education credits.
Course Delivery Format: Asynchronous Distance Learning-interaction includes quizzes with questions and answers, post-tests. This module is Reading-Based Online.
New York State Education Department, Office of the Professions, Division of Professional Licensing Services, Social Work Unit
Relias, LLC is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0009.
Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of licensed master social work and licensed clinical social work in New York. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice for an LMSW and LCSW. A licensee who practices beyond the authorized scope of practice could be charged with unprofessional conduct under the Education Law and Regents Rules.
As a provider of online, asynchronous education, some courses offered by Relias Learning are considered “self-study” under section 74.10(c)(2)(ii)(b)(4) of the Commissioner’s Regulations. The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.
Social workers will receive 3.75 continuing education hours for participating in this course. This activity is approved for 3.75 contact hours.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 3.75 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
Florida Board of Medicine
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 3.75 AMA PRA category 1 Credits™.
Florida Physician Assistants
Florida Physician Assistants (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 3.75 contact hours for participating in this course.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 3.75 AMA PRA category 1 Credits™.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 3.75 AMA PRA category 1 Credits™.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 3.75 AMA PRA category 1 Credits™.
South Carolina Board of Social Work Examiners
South Carolina Board of Social Work Examiners (CEBroker Provider 50-290)
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 3.75 contact hours for participating in this course.
West Virginia Board of Social Work
West Virginia Board of Social Work (CEBroker Provider #50-290)
South Carolina Board of Examiners for Licensure of Professional Counselors and Therapists
South Carolina Board of Examiners for Licensure of Professional Counselors and Therapists (CEBroker Provider #50-290)
New Mexico Medical Board
Physicians will receive 3.75 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 3.75 AMA PRA category 1 Credits™
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-21-083-H01-P
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-21-083-H01-T
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 3.75 contact hours.
Define drug diversion and identify various classifications of medications that are diverted or abused.
Recognize rationales for prescription drug diversion.
Recognize and prevent drug diversion behaviors and activities.
Identify tools to detect and deter drug diversion.
Define key terms necessary to understand SUD.
Name common controlled and noncontrolled medications that are abused.
Describe screening and assessment tools helpful in identifying SUD.
Describe the nonpharmacological and pharmacological treatments of SUD.
Define specific types of pain.
Identify options for pain management using the most recent CDC guidelines.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Drug Classifications and Diversion
Defining Drug Diversion
Classifications
State-Level Classifications
Further Categorization
Legal Ramifications
Review
Summary
Section 3: Rationales and Behaviors
Rationales for Diversion
Income-Driven Diversion
Substance Use and Self-Medication
Common Diversion Methods to Obtain Prescription Medications
Common Drug Diversion Behaviors in Clinical Practice
Individual Patient Behaviors
Prescriber and Support Staff Behaviors
Meet JT
A Pill Mill
An Oxycodone Addiction
The Small-Town Pharmacist
Sharing Medications
Review
Summary
Section 4: Detection and Prevention
Patient Histories and Physical Assessment
Prescription Drug Monitoring Programs (PDMPs)
Patient-Prescriber Agreements or “Narcotics Contracts”
Drug Screens
Prevention of Diversion and Abuse Checklist
Pharmacist Refusal to Fill Prescriptions
Patient Counseling and Drug Regimen Review
Diagnosis Verification
Reporting Diversion
Review
Summary
Section 5: Substance Use Disorders
Scope of the Problem
Definitions
Review
Summary
Section 6: The Reward Pathway of the Brain
Anatomy and Physiology
Factors Contributing to Addiction
Review
Summary
Section 7: Signs, Symptoms, and Substances Used
Signs and Symptoms
Illicit, Prescription, and OTC Substances
Review
Summary
Section 8: Screening and Treatment of SUD
Screening
Nonpharmacological Treatment of SUD
Detoxification
Pharmacological Treatment of SUD
Naloxone Treatment of Opioid Overdose
Review
Summary
Section 9: Defining and Managing Pain
Pain
Neuropathic Pain
Nociceptive Pain
Acute vs. Chronic Pain
Pain Management
Trends in Pain Management
Prescribing Rates and Drug Overdose
Review
Summary
Section 10: Assessment and Establishing Goals of Treatment
Assessment
Pain Scores
Activities of Daily Living
Psychiatric Assessment
Expectations of Pain Management
Review
Summary
Section 11: Treatment of Pain
Nonpharmacological Treatment
Pharmacological Management of Nociceptive Pain
Chronic Neuropathic Pain
Adjuvant Drug Therapy
Opioid-Related Pain Management Recommendations
Review
Summary
Section 12: Pain Management in Patients with SUD
Treatment of Pain
Acute Pain Treatment in SUD
Chronic Pain Management in SUD
Review
Summary
Section 13: Conclusion
Course Summary
Course Contributors
Resources
References
Instructor: Doug Raiff, PharmD, BCPS
Doug earned his Doctor of Pharmacy (PharmD) from the Raabe College of Pharmacy at Ohio Northern University in 2011. He completed a PGY-1 residency in Pharmacy Practice at MetroHealth Medical Center in Cleveland, Ohio, and completed a specialty residency in Drug Information and Medical Information at Duke University Hospital and GlaxoSmithKline. He is a board-certified pharmacotherapy specialist, and has worked as a clinical pharmacist within the Center for Medication Policy of the Duke University Health System since 2013. His primary responsibilities include chairing the Pharmaceutical Utilization Management Program and Medication Alert Optimization Committee for the health system. He also serves as an APPE preceptor, PGY-1 residency coordinator, and is a member of the Duke University Health System Institutional Review Board. Disclosure: Doug Raiff, PharmD, BCPS has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.Instructor: Johnny J. Bethea, II, BSPharm
Johnny earned his B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Immunizations, and Asthma Therapy Management. He serves as Director of Clinical Pharmacy Services for Relias and has over 15 years of experience serving in areas of behavioral health including as a psychiatric consultant pharmacist and the pharmaceutical industry. He develops clinical analytic solutions and provides clinical considerations. He has served on the Executive Board of Directors for CMHCs and other medical organizations. He has also served as a cardiovascular consultant pharmacist, pharmacy manager, as an APPE preceptor, and on the college of pharmacy dean’s advisory council. Disclosure: Johnny J. Bethea, II, BSPharm has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
The target audience for this course is: Nurses; Pharmacists; Physician Assistants; Physicians; in the following settings: All Healthcare Settings.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
